TUDOR INVESTMENT CORP ET AL - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$791,358
+198.6%
94,660
+111.1%
0.01%
+33.3%
Q3 2022$265,000
-47.9%
44,841
+193.1%
0.01%
-25.0%
Q3 2021$509,000
-33.8%
15,300
-22.8%
0.01%
-46.7%
Q2 2021$769,000
-7.5%
19,824
+24.0%
0.02%
-34.8%
Q4 2020$831,000
+422.6%
15,983
-1.1%
0.02%
+64.3%
Q1 2020$159,000
-42.2%
16,160
-52.7%
0.01%
+27.3%
Q1 2019$275,000
+30.3%
34,196
+91.6%
0.01%
+120.0%
Q3 2017$211,000
+47.6%
17,848
-24.1%
0.01%
+66.7%
Q2 2016$143,00023,5160.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders